Announced Fri, 26 Jun · 12:15 IST
Indoco Remedies Goa Plant clears Malta Medicines Authority audit
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.9%1-day move
₹231.00
prior close
₹237.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.5-0.2+1.0+3.9+2.8+6.3+5.2+2.2+8.2+6.0———
Up moveDown movePending
AI summary
Indoco Remedies Goa Plant-I, which makes solid oral dosage forms, has received EU GMP certification from the Malta Medicines Authority after an inspection held in November 2025. The certification confirms the facility meets Good Manufacturing Practice standards under the EC Directive, strengthening Indoco's access to European regulated markets. Indoco runs 10 manufacturing facilities and reports about US dollar 175 million turnover.
Likely market impact
Positive for export prospects into Europe; reinforces regulatory credentials and supports future approvals in advanced markets.